ArticleBlood science (Baltimore, Md.)2025

Daratumumab in relapsed or refractory immune thrombocytopenic purpura.

Ciprian Tomuleasa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.